Table 1.
Demographic data, HIV disease characteristics, and hepatitis C virus co-infection by HIV subtype and by study group.
| Subtype B n = 27 |
Subtype C n = 25 |
HIV- n = 19 |
P-value B vs. C |
P-value, HIV+ vs. HIV− |
|
|---|---|---|---|---|---|
| Age, y, median (IQR) | 44 (37,50) | 43 (35, 47) | 41 (38, 48) | 0.33 | 0.76 |
| Gender | 0.419 | 0.073 | |||
| - Male, n (%) | 14 (52) | 10 (40) | 14 (74) | ||
| - Female, n (%) | 13 (48) | 15 (60) | 5 (26) | ||
| AIDS, n (%) | 21 (78) | 18 (72) | - | 0.75 | - |
| ART, n (%) | 24 (89) | 16 (64) | - | 0.049 | - |
| Current CD41 | 457 (255, 607) |
372 (196, 367) | - | 0.19 | - |
| Nadir CD41 | 83 (42, 232) | 175 (31, 347) | - | 0.25 | - |
| Duration of infection1(months) | 87 (76, 130) | 79 (26, 136) | - | 0.47 | - |
| HCV2 (%) | 6 (22) | 2 (8) | 0 | 0.25 | - |
| Plasma log10 viral load | 1.70 (1.70, 1.81) |
2.92 (1.70, 3.77) |
- | 0.008 | - |
| Plasma viral load <50, n (%) | 20 (74) | 8 (32) | - | 0.005 | - |
1
Median (IQR)
2
Hepatitis C virus (HCV) serostatus was assessed using an HCV antibody test (Abbott-Architect).